Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man

E. R. Block, J. E. Bennett, L. G. Livoti, W. J. Klein, R. R. MacGregor, L. Henderson

Research output: Contribution to journalArticle

Abstract

The efficacy of hemodialysis in removing flucytosine (5 fluorocytosine) and amphotericin B from blood was studied in 8 adult patients with renal failure who required chronic hemodialysis; the results were correlated with the protein binding of these drugs. Creatinine, flucytosine, and amphotericin B concentrations were measured immediately before and after dialysis, as well as in arterial samples of blood entering and leaving the artificial kidney after 2, 4, or 6 hours of hemodialysis. Clearances of flucytosine and creatinine by the artificial kidney were indistinguishable, and both increased linearly with blood flow through the dialyzer. These results were consistent with the minimal protein binding (90%) protein bound, poorly dialyzable, and the clearance rate by the artificial kidney ranged from 3% to 15% of that for creatinine. From these data, recommended dosage schedules for flucytosine and amphotericin B, when used to treat fungal infections in patients undergoing hemodialysis, were developed.

Original languageEnglish (US)
Pages (from-to)613-617
Number of pages5
JournalAnnals of Internal Medicine
Volume80
Issue number5
StatePublished - 1974
Externally publishedYes

Fingerprint

Flucytosine
Amphotericin B
Artificial Kidneys
Renal Dialysis
Creatinine
Protein Binding
Mycoses
Renal Insufficiency
Dialysis
Appointments and Schedules
Carrier Proteins
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Block, E. R., Bennett, J. E., Livoti, L. G., Klein, W. J., MacGregor, R. R., & Henderson, L. (1974). Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man. Annals of Internal Medicine, 80(5), 613-617.

Flucytosine and amphotericin B : hemodialysis effects on the plasma concentration and clearance. Studies in man. / Block, E. R.; Bennett, J. E.; Livoti, L. G.; Klein, W. J.; MacGregor, R. R.; Henderson, L.

In: Annals of Internal Medicine, Vol. 80, No. 5, 1974, p. 613-617.

Research output: Contribution to journalArticle

Block, ER, Bennett, JE, Livoti, LG, Klein, WJ, MacGregor, RR & Henderson, L 1974, 'Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man', Annals of Internal Medicine, vol. 80, no. 5, pp. 613-617.
Block ER, Bennett JE, Livoti LG, Klein WJ, MacGregor RR, Henderson L. Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man. Annals of Internal Medicine. 1974;80(5):613-617.
Block, E. R. ; Bennett, J. E. ; Livoti, L. G. ; Klein, W. J. ; MacGregor, R. R. ; Henderson, L. / Flucytosine and amphotericin B : hemodialysis effects on the plasma concentration and clearance. Studies in man. In: Annals of Internal Medicine. 1974 ; Vol. 80, No. 5. pp. 613-617.
@article{4babc41b116a463a98cc9ea4925fdb44,
title = "Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man",
abstract = "The efficacy of hemodialysis in removing flucytosine (5 fluorocytosine) and amphotericin B from blood was studied in 8 adult patients with renal failure who required chronic hemodialysis; the results were correlated with the protein binding of these drugs. Creatinine, flucytosine, and amphotericin B concentrations were measured immediately before and after dialysis, as well as in arterial samples of blood entering and leaving the artificial kidney after 2, 4, or 6 hours of hemodialysis. Clearances of flucytosine and creatinine by the artificial kidney were indistinguishable, and both increased linearly with blood flow through the dialyzer. These results were consistent with the minimal protein binding (90{\%}) protein bound, poorly dialyzable, and the clearance rate by the artificial kidney ranged from 3{\%} to 15{\%} of that for creatinine. From these data, recommended dosage schedules for flucytosine and amphotericin B, when used to treat fungal infections in patients undergoing hemodialysis, were developed.",
author = "Block, {E. R.} and Bennett, {J. E.} and Livoti, {L. G.} and Klein, {W. J.} and MacGregor, {R. R.} and L. Henderson",
year = "1974",
language = "English (US)",
volume = "80",
pages = "613--617",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "5",

}

TY - JOUR

T1 - Flucytosine and amphotericin B

T2 - hemodialysis effects on the plasma concentration and clearance. Studies in man

AU - Block, E. R.

AU - Bennett, J. E.

AU - Livoti, L. G.

AU - Klein, W. J.

AU - MacGregor, R. R.

AU - Henderson, L.

PY - 1974

Y1 - 1974

N2 - The efficacy of hemodialysis in removing flucytosine (5 fluorocytosine) and amphotericin B from blood was studied in 8 adult patients with renal failure who required chronic hemodialysis; the results were correlated with the protein binding of these drugs. Creatinine, flucytosine, and amphotericin B concentrations were measured immediately before and after dialysis, as well as in arterial samples of blood entering and leaving the artificial kidney after 2, 4, or 6 hours of hemodialysis. Clearances of flucytosine and creatinine by the artificial kidney were indistinguishable, and both increased linearly with blood flow through the dialyzer. These results were consistent with the minimal protein binding (90%) protein bound, poorly dialyzable, and the clearance rate by the artificial kidney ranged from 3% to 15% of that for creatinine. From these data, recommended dosage schedules for flucytosine and amphotericin B, when used to treat fungal infections in patients undergoing hemodialysis, were developed.

AB - The efficacy of hemodialysis in removing flucytosine (5 fluorocytosine) and amphotericin B from blood was studied in 8 adult patients with renal failure who required chronic hemodialysis; the results were correlated with the protein binding of these drugs. Creatinine, flucytosine, and amphotericin B concentrations were measured immediately before and after dialysis, as well as in arterial samples of blood entering and leaving the artificial kidney after 2, 4, or 6 hours of hemodialysis. Clearances of flucytosine and creatinine by the artificial kidney were indistinguishable, and both increased linearly with blood flow through the dialyzer. These results were consistent with the minimal protein binding (90%) protein bound, poorly dialyzable, and the clearance rate by the artificial kidney ranged from 3% to 15% of that for creatinine. From these data, recommended dosage schedules for flucytosine and amphotericin B, when used to treat fungal infections in patients undergoing hemodialysis, were developed.

UR - http://www.scopus.com/inward/record.url?scp=0016224225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016224225&partnerID=8YFLogxK

M3 - Article

C2 - 4823813

AN - SCOPUS:0016224225

VL - 80

SP - 613

EP - 617

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 5

ER -